Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Whelan

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1988
Comparative in vitro cytotoxicities of adriamycin (ADM) and 4'[(9-acridinyl)-amino] methane sulphon-m-anisidide (mAMSA)B T Hill, R D Whelan
Journal of the National Cancer Institute|August 1, 1981
Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell linesB T Hill, R D Whelan
Cancer Treatment Reviews|September 1, 1980
Comparative effects of vincristine and vindesine on cell cycle kinetics in vitroB T Hill, R D Whelan
Cancer Chemotherapy and Pharmacology|January 1, 1982
Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivitiesB T Hill, R D Whelan
Cell Biology International Reports|December 1, 1981
The influence of agarose concentration on the cloning efficiency of a series of established human cell linesR D Whelan, B T Hill
Investigational New Drugs|January 1, 1986
Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugsB T Hill, R D Whelan
Gerontology|January 1, 1978
Studies on the degradation of ageing chromatin DNA by nuclear and cytoplasmic factors and deoxyribonucleasesB T Hill, R D Whelan
Oncogene|May 20, 1998
Loss of protein kinase C function induces an apoptotic responseR D Whelan, P J Parker
Biochemistry|March 8, 1988
Infinite-cis kinetics support the carrier model for erythrocyte glucose transportT J Wheeler, J D Whelan
European Journal of Cancer|December 1, 1980
Antitumour activity and cell kinetic effects of pyrazofurin in vitroB T Hill, R D Whelan
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Cancer Chemotherapy and Pharmacology|January 1, 1988
Comparative in vitro cytotoxicities of adriamycin (ADM) and 4'[(9-acridinyl)-amino] methane sulphon-m-anisidide (mAMSA)B T Hill, R D Whelan
Journal of the National Cancer Institute|August 1, 1981
Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell linesB T Hill, R D Whelan
Cancer Treatment Reviews|September 1, 1980
Comparative effects of vincristine and vindesine on cell cycle kinetics in vitroB T Hill, R D Whelan
Cancer Chemotherapy and Pharmacology|January 1, 1982
Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivitiesB T Hill, R D Whelan
Cell Biology International Reports|December 1, 1981
The influence of agarose concentration on the cloning efficiency of a series of established human cell linesR D Whelan, B T Hill
Investigational New Drugs|January 1, 1986
Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugsB T Hill, R D Whelan
Gerontology|January 1, 1978
Studies on the degradation of ageing chromatin DNA by nuclear and cytoplasmic factors and deoxyribonucleasesB T Hill, R D Whelan
Oncogene|May 20, 1998
Loss of protein kinase C function induces an apoptotic responseR D Whelan, P J Parker
Biochemistry|March 8, 1988
Infinite-cis kinetics support the carrier model for erythrocyte glucose transportT J Wheeler, J D Whelan
European Journal of Cancer|December 1, 1980
Antitumour activity and cell kinetic effects of pyrazofurin in vitroB T Hill, R D Whelan
Pageof 15